Stephens Investment Management Group LLC trimmed its holdings in Balchem Corporation (NASDAQ:BCPC) by 0.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 396,616 shares of the basic materials company’s stock after selling 629 shares during the quarter. Stephens Investment Management Group LLC owned about 1.24% of Balchem Corporation worth $30,821,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Capital Analysts LLC purchased a new position in Balchem Corporation in the 2nd quarter worth approximately $197,000. Municipal Employees Retirement System of Michigan lifted its stake in Balchem Corporation by 4.0% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 7,500 shares of the basic materials company’s stock worth $583,000 after purchasing an additional 290 shares in the last quarter. Great West Life Assurance Co. Can lifted its stake in Balchem Corporation by 3.8% in the 2nd quarter. Great West Life Assurance Co. Can now owns 45,991 shares of the basic materials company’s stock worth $3,570,000 after purchasing an additional 1,678 shares in the last quarter. Turner Investments LLC lifted its stake in Balchem Corporation by 25.0% in the 2nd quarter. Turner Investments LLC now owns 2,500 shares of the basic materials company’s stock worth $194,000 after purchasing an additional 500 shares in the last quarter. Finally, Tributary Capital Management LLC lifted its stake in Balchem Corporation by 11.9% in the 2nd quarter. Tributary Capital Management LLC now owns 187,925 shares of the basic materials company’s stock worth $14,604,000 after purchasing an additional 19,973 shares in the last quarter. 84.22% of the stock is currently owned by institutional investors and hedge funds.
Balchem Corporation (BCPC) traded down 0.11% on Tuesday, reaching $75.49. 4,876 shares of the company’s stock were exchanged. Balchem Corporation has a 12-month low of $65.37 and a 12-month high of $89.50. The company has a market cap of $2.41 billion, a P/E ratio of 39.11 and a beta of 1.10. The firm has a 50 day moving average of $75.50 and a 200-day moving average of $79.34.
Balchem Corporation (NASDAQ:BCPC) last issued its earnings results on Friday, August 4th. The basic materials company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.01. The company had revenue of $147.08 million for the quarter. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%. Equities analysts expect that Balchem Corporation will post $2.48 EPS for the current fiscal year.
Separately, BidaskClub lowered shares of Balchem Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, June 21st.
In other news, Director Edward Mcmillan sold 2,557 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $81.09, for a total value of $207,347.13. Following the sale, the director now directly owns 25,739 shares in the company, valued at $2,087,175.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.59% of the stock is owned by corporate insiders.
About Balchem Corporation
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.